XRP Payments Coming to 6,000 US Pharmacies in New $50M Healthcare Deal

The agreement allows Wellgistics to draw funds at its discretion, potentially issuing shares in exchange for capital. The move positions the firm to accelerate the deployment of its XRP-powered payment framework across over 6,000 independent pharmacies and over 150 contracted manufacturers nationwide. XRP will serve dual functions in the system: first, as a balance sheet holding, and second, as the native asset to facilitate on-ledger payments between pharmacies, distributors, and manufacturers.

By operating through the XRP Ledger, Wellgistics aims to bypass traditional ACH systems and reduce transaction times from days to seconds while cutting transfer fees to fractions of a cent. According to statements from company executives, the model is designed to provide faster rebate settlements and credit provisioning for pharmacy partners, potentially improving liquidity and operational efficiency.

Wellgistics CEO Brian Norton said in the announcement that the firm is “challenging the idea that healthcare has to be tethered to legacy systems.” He described the new structure as a move toward disintermediating slow, manual finance flows within healthcare logistics, saying,  “I strongly believe that our XRP initiative positions Wellgistics Health years ahead of the curve-and squarely at the center of where healthcare and fintech converge.”

CFO Mark DiSiena noted the XRP framework was designed to “unlock capital velocity with surgical precision.” The decision coincides with mounting infrastructure around XRP in institutional markets. CME Group is set to launch two cash-settled futures contracts for XRP on May 19, micro contracts at 2,500 XRP and standard lots at 50,000 XRP.

These will provide regulated exposure to the token through the Chicago Mercantile Exchange and are expected to contribute to broader price discovery and liquidity for XRP. While the futures products are not connected to Wellgistics’ operations, their debut may help reduce risk perceptions around XRP as a corporate holding or transaction asset.